glp-1/gin medications List of approved and pending GLP-1 Balancing Gut Support Blend GLP-1 Booster Capsules, Berberine +

GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy

What are the coverage criteriaBMI, step therapy, lifestyle documentation

Once available, retatrutide will likely be administered as a weekly injection under the skin (subcutaneous)

Thyroid Health: We prioritize safety by screening for personal or family history of medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia syndrome type 2 before recommending semaglutide, given its associated risks